Search Results - "Boulbair, F"

EP-1335: Efficacy and safety of hypofractionated loco-regional radiotherapy for breast cancer patients by Caubet, M., Bontemps, P., Anota, A., Boulbair, F., Hammoud, Y., Peigneaux, K., Créhange, G., De Bari, B.

Get full text

EP-1047: VMAT for accelerated partial breast irradiation (IPAS) by Fenoglietto, P, Boulbair, F, Lemanski, C, Charissoux, M, Llaccer, C

Get full text

Accelerated Partial Breast Irradiation With Volumetric Modulated Arc Therapy: Feasibility and Early Clinical Results at the Montpellier Cancer Institute by Fenoglietto, P, Riou, O, Boulbair, F, Lemanski, C, Charissoux, M, Llacer Moscardo, C, Ailleres, N, Dubois, J, Bourgier, C, Azria, D

Get full text

PO-1442 Fractionated stereotactic radiotherapy (SRS) for brain metastases: a single institution analysis by Garnier, L., Lestrade, L., Falcoz, A., Henriques, J., Boulbair, F., Rouvier, J., Vernerey, D., Hammoud, Y., De Bari, B.

Get full text

PO-1320 Pelvic chemoradiation after chemotherapy in patients with advanced anal squamous cell carcinoma by Boustani, J., Grave, A., De Bari, B., Mandy, P., Boulbair, F., Benhmida, S., Noirclerc, M., Monasterolo, P., Kim, S., Borg, C.

Get full text

Updated data of epitopes-HPV02 trial and external validation of efficacy of DCF in prospective epitopes-HPV01 study in advanced anal squamous cell carcinoma. Pooled analysis of 115 patients by Kim, S., Meurisse, A., Stouvenot, M., Jary, M., Hon, T Nguyen Tan, Francois, E., Buecher, B., Andre, T., Samalin, E., Boulbair, F., De Bari, B., Almotlak, H., Klajer, E., Calcagno, F., Chatillon, E., Spehner, L., Jacquin, M., Vendrely, V., Vernerey, D., Borg, C.

Get full text

534P - Updated data of epitopes-HPV02 trial and external validation of efficacy of DCF in prospective epitopes-HPV01 study in advanced anal squamous cell carcinoma. Pooled analysis of 115 patients by Kim, S., Meurisse, A., Stouvenot, M., Jary, M., Hon, T Nguyen Tan, Francois, E., Buecher, B., Andre, T., Samalin, E., Boulbair, F., De Bari, B., Almotlak, H., Klajer, E., Calcagno, F., Chatillon, E., Spehner, L., Jacquin, M., Vendrely, V., Vernerey, D., Borg, C.

“…The addition of docetaxel to cisplatin and 5FU (DCF) has shown a promising efficacy in Epitopes-HPV01 study with 4 of first 8 consecutive patients presenting a…”
Get full text

534PUpdated data of epitopes-HPV02 trial and external validation of efficacy of DCF in prospective epitopes-HPV01 study in advanced anal squamous cell carcinoma. Pooled analysis of 115 patients by Kim, S, Meurisse, A, Stouvenot, M, Jary, M, Hon, T Nguyen Tan, Francois, E, Buecher, B, Andre, T, Samalin, E, Boulbair, F, Bari, B De, Almotlak, H, Klajer, E, Calcagno, F, Chatillon, E, Spehner, L, Jacquin, M, Vendrely, V, Vernerey, D, Borg, C

“…Abstract Background The addition of docetaxel to cisplatin and 5FU (DCF) has shown a promising efficacy in Epitopes-HPV01 study with 4 of first 8 consecutive…”
Get full text

Radiothérapie hypofractionnée en split course de patients âgés et fragiles atteints d’un cancer de la tête et du cou localement évolué : étude de 58 cas by Benhmida, S., Sun, R., Gherga, E., Hammoud, Y., Lestrade, L., Boulbair, F., Mauvais, O., Bontemps, P., Thariat, J., Bourhis, J., Sun, X.S.

“…Évaluer l’efficacité et la tolérance d’une radiothérapie hypofractionnée en split course des cancers de la tête et du cou chez 58 patients (âgés ou en mauvais…”
Get full text

Arcthérapie volumétrique modulée (VMAT) partielle accélérée du sein : premiers résultats cliniques à l’Institut du cancer de Montpellier by Riou, O., Fenoglietto, P., Lauche, O., Boulbair, F., Lemanski, C., Charissoux, M., Llacer Moscardo, C., Aillères, N., Dubois, J., Bourgier, C., Azria, D.

Get full text

Acthérapie modulée volumétrique partielle accélérée du sein : résultats dosimétriques des premières patientes traitées au centre régional de lutte contre le cancer Val-d’Aurelle de Montpellier by Boulbair, F., Fenoglietto, P., Lemanski, C., Charissoux, M., Llacer Moscardo, C., Aillères, N., Dubois, J.-B., Azria, D.

Get full text

Infiltrating carcinoma of the uterine cervix: epidemiology, prognostic factors, therapeutic strategies by Pereira, R, Renard, A, Boulbair, F, Touboul, E, Lefranc, J P

“…In industrialized countries cervical cancer has decreased over the past decades. This, thanks to wide spread screening campaigns of precancerous lesions and…”
Get full text

Carcinomes infiltrants du col utérin : épidémiologie, facteurs pronostiques, stratégie thérapeutique: Les tumeurs gynécologiques (hors sein) by PEREIRA, R, RENARD, A, BOULBAIR, F, TOUBOUL, E, LEFRANC, J.-P

Get full text

Évaluation d'une nouvelle échelle de toxicités tardives de la radiothérapie: la SOMA by Boulbair, F, Pavy, JJ, Bontemps, P, Bosset, JF, Schraub, S

Get full text

Radiothérapie accélérée (70,2 Gy, 5,5 semaines) dans les cancers avancés de la tête et du cou: résultats d'un essai phase II. À propos de 49 patients traités pour un carcinome épidermoïde de l'oropharynx by Bontemps, P, Boulbair, F, Pavy, JJ, Badet, JM, Bosset, JF, Schraub, S

Get full text